GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (OSTO:NANOo) » Definitions » Float Percentage Of Total Shares Outstanding

Thor Medical ASA (OSTO:NANOO) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 14, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Thor Medical ASA's float shares is 0.00 Mil. Thor Medical ASA's total shares outstanding is 233.54 Mil. Thor Medical ASA's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Thor Medical ASA's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Thor Medical ASA's Institutional Ownership is 0.26%.

Thor Medical ASA Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Thor Medical ASA's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/233.54
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thor Medical ASA (OSTO:NANOO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (OSTO:NANOo) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
OSL:LYTIX OSL:ABS OSL:EXTX OSL:CIRCA OSL:PCIB OSL:ABTEC OSL:SOFTX OSL:CRNA OSL:BGBIO OSL:HBC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
TRMED:Norway 0R6Y:UK 8NN:Germany
Address
Kjelsasveien 168 B, Oslo, NOR, 0884
Website
https://www.nordicnanovector.com
Nordic Nanovector ASA is a biopharmaceutical company. It is engaged in the development and commercialization of targeted therapeutics to improve the lives of patients with haematological cancers, such as non-Hodgkin lymphoma and leukaemia. The company's main clinical stage product is Betalutin.

Thor Medical ASA (OSTO:NANOO) Headlines

No Headlines